Serum

'Sitting Over 200 Million Vials': Poonawalla Says Serum Institute Has Halted Production Of Covid Vaccines

Covovax First Indian COVID Vaccine To Be Sold In Europe, Says SII's Adar Poonawalla

Covishield, Covaxin Prices Revised For Private Hospitals Day Before Booster Drive Begins — Check Rates

SII's Covovax Gets Emergency Approval For Children Aged 12-17 Years

COVID Vaccine: Govt Panel Recommends Permission For Phase-3 Trial Of Covovax As Booster Dose In Adults

Serum Institute Seeks EUA For Its Covovax Vaccine For 12-17 Years Age Group

Covishield, Covaxin Granted Regular Market Approval For Use In Adult Population

Prices Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Regular Market Approval

SII Gets DCGI Nod To Manufacture Drug Substance, Test It For Developing Jab Against Omicron

CDSCO Panel Recommends Emergency Use Authorisation For SII's Covid vaccine Covovax

Covid Crisis | WHO approves SII's COVOVAX for emergency use

WHO approves Covovax, tweets Serum Institute's Adar Poonawalla